Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|September 27, 2001
BMS-204352 (Bristol Myers Squibb)K B MackayBrain Research|April 11, 1994
Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brainK B Mackay, J McCullochJournal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
kappa-1 Opioid receptors of the temporal cortex are preserved in Alzheimer's diseaseK B Mackay, D Dewar, J McCullochBrain Research|March 27, 1992
The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemiaK Kusumoto, K B Mackay, J McCullochExperimental Neurology|February 1, 1997
Intracortical glutamate perfusion in vivo induces cellular alterations in specific protein kinase C isoforms and amyloid precursor proteinK Horsburgh, K B Mackay, J McCullochTrends in Pharmacological Sciences|April 29, 1998
To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?A J Hunter, K B Mackay, D C RogersBrain Research|July 9, 1993
Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's diseaseM Ikeda, K B Mackay, D Dewar, et al.Brain Research|November 26, 1993
Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the ratK B Mackay, K Kusumoto, D I Graham, et al.Brain Research|August 6, 1993
Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977K B Mackay, K Kusumoto, D I Graham, et al.Molecular and Cellular Endocrinology|November 1, 1992
Atrial natriuretic peptide effects in AtT-20 pituitary tumour cellsA F Gilkes, K B MacKay, G Cramb, et al.Pageof 2